Impact of tafamidis in Colombian patients diagnosed with ATTR-CA in quality of life during two year of follow up

06/11/2023
10/07/2025
EU PAS number:
EUPAS105913
Study
Ongoing
Documents
Study protocol
Initial protocol
English (742.07 KB - PDF) View document
Updated protocol
English (527.95 KB - PDF) View document
Study results
Study report
Other information